This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
To accelerate the development of next-generation radioconjugates to treat cancer
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
Both organisations enter into a long- term collaboration to expand patient access in India
Mungara has over 25+ years of experience in the supply chain domain
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
It is the first autotaxin inhibitor to be investigated in cancer patients
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Subscribe To Our Newsletter & Stay Updated